Concert Pharmaceuticals, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/131d6ed8-7191-4668-8e08-1adca8617e24/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-77.5M | 2021-01-01 – 2021-12-31 | evidence 0001367920-22-000018 |
| FY 2020 | $-72.6M | 2020-01-01 – 2020-12-31 | evidence 0001367920-21-000013 |
| FY 2019 | $-79.0M | 2019-01-01 – 2019-12-31 | evidence 0001367920-20-000013 |
| FY 2018 | $-55.6M | 2018-01-01 – 2018-12-31 | evidence 0001367920-19-000009 |
| FY 2017 | $92.6M | 2017-01-01 – 2017-12-31 | evidence 0001367920-18-000012 |
| FY 2016 | $-51.2M | 2016-01-01 – 2016-12-31 | evidence 0001367920-17-000009 |
| FY 2015 | $24.8M | 2015-01-01 – 2015-12-31 | evidence 0001367920-16-000014 |
| FY 2014 | $-30.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-073586 |
| FY 2013 | $-4.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-073586 |
| FY 2012 | $-18.6M | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-073586 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Concert Pharmaceuticals, Inc. — all facts · Revenue · Net Income